Stock & Company Details
Candel Therapeutics Inc $CADL
Price:
N/A
N/A
77M
$868M
52 Week High:
N/A
10 Day Average Volume:
N/A
-11.60
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CADL technical indicators
Latest Candel Therapeutics Inc (CADL) indicator readings as of 2026-09-18.
CADL's 14-day RSI is 41.9, in neutral territory. At $10.85 it is trading 41.1% above its 200-day moving average of $7.69, and below its 50-day average of $11.21. Price sits near the lower Bollinger Band ($10.24 to $14.39). ADX reads 33.9, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Finance Bot
Ask your questions
Start by typing a question below.
